Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal.

Wan MT, Ming ME.

Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16785. [Epub ahead of print]

PMID:
29766492
2.

Association of Marital Status With T Stage at Presentation and Management of Early-Stage Melanoma.

Sharon CE, Sinnamon AJ, Ming ME, Chu EY, Fraker DL, Karakousis GC.

JAMA Dermatol. 2018 Apr 18. doi: 10.1001/jamadermatol.2018.0233. [Epub ahead of print]

PMID:
29710174
3.

The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.

Sinnamon AJ, Sharon CE, Song Y, Neuwirth MG, Elder DE, Xu X, Chu EY, Ming ME, Fraker DL, Gimotty PA, Karakousis GC.

J Am Acad Dermatol. 2018 Mar 5. pii: S0190-9622(18)30352-9. doi: 10.1016/j.jaad.2018.02.066. [Epub ahead of print]

PMID:
29518458
4.

Impact of a Smartphone Application on Skin Self-Examination Rates in Patients that are New to Total Body Photography: A Randomized Controlled Trial.

Marek AJ, Chu EY, Ming ME, Khan ZA, Kovarik CL.

J Am Acad Dermatol. 2018 Feb 10. pii: S0190-9622(18)30211-1. doi: 10.1016/j.jaad.2018.02.025. [Epub ahead of print] No abstract available.

PMID:
29438760
5.

Management Strategies of Academic Pigmented Lesion Clinic Directors in the United States.

Nelson KC, Grossman D, Kim CC, Chen SC, Curiel-Lewandrowski CN, Grichnik JM, Kirkwood JM, Leachman SA, Marghoob AA, Swetter SM, Venna SS, Ming ME.

J Am Acad Dermatol. 2018 Jan 4. pii: S0190-9622(18)30011-2. doi: 10.1016/j.jaad.2017.12.069. [Epub ahead of print] No abstract available.

PMID:
29307637
6.

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.

Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, Jeter JM, Kim CC, Kirkwood JM, Mangold AR, Meyskens F, Ming ME, Nelson KC, Piepkorn M, Pollack BP, Robinson JK, Sober AJ, Trotter S, Venna SS, Agarwala S, Alani R, Averbook B, Bar A, Becevic M, Box N, E Carson W 3rd, Cassidy PB, Chen SC, Chu EY, Ellis DL, Ferris LK, Fisher DE, Kendra K, Lawson DH, Leming PD, Margolin KA, Markovic S, Martini MC, Miller D, Sahni D, Sharfman WH, Stein J, Stratigos AJ, Tarhini A, Taylor MH, Wisco OJ, Wong MK.

Melanoma Manag. 2017 Mar;4(1):13-37. doi: 10.2217/mmt-2016-0022. Epub 2017 Mar 1. Review.

7.

Association Between Patient Age and Lymph Node Positivity in Thin Melanoma.

Sinnamon AJ, Neuwirth MG, Yalamanchi P, Gimotty P, Elder DE, Xu X, Kelz RR, Roses RE, Chu EY, Ming ME, Fraker DL, Karakousis GC.

JAMA Dermatol. 2017 Sep 1;153(9):866-873. doi: 10.1001/jamadermatol.2017.2497.

PMID:
28724122
8.

Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas.

Miller CJ, Shin TM, Sobanko JF, Sharkey JM, Grunyk JW, Elenitsas R, Chu EY, Capell BC, Ming ME, Etzkorn JR.

J Am Acad Dermatol. 2017 Aug;77(2):333-340.e1. doi: 10.1016/j.jaad.2017.03.025.

PMID:
28711085
9.

Commentary: The quest for an improved risk stratification tool for patients with melanoma.

Ming ME.

J Am Acad Dermatol. 2017 May;76(5):826-828. doi: 10.1016/j.jaad.2017.02.045. No abstract available.

PMID:
28411773
10.

Assessment of smartphone applications for total body digital photography-guided skin exams by patients.

Marek AJ, Chu EY, Ming ME, Kovarik CL.

J Am Acad Dermatol. 2016 Nov;75(5):1063-1064.e1. doi: 10.1016/j.jaad.2016.06.005. No abstract available.

11.

Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma.

Mochel MC, Ming ME, Imadojemu S, Gangadhar TC, Schuchter LM, Elenitsas R, Payne AS, Chu EY.

J Cutan Pathol. 2016 Sep;43(9):787-91. doi: 10.1111/cup.12735. Epub 2016 Jun 1.

PMID:
27161449
12.

Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma.

Marek AJ, Ming ME, Bartlett EK, Karakousis GC, Chu EY.

JAMA Dermatol. 2016 Jul 1;152(7):836-7. doi: 10.1001/jamadermatol.2016.0875. No abstract available.

13.

Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity.

Bartlett EK, Peters MG, Blair A, Etherington MS, Elder DE, Xu XG, Guerry D, Ming ME, Fraker DL, Czerniecki BJ, Gimotty PA, Karakousis GC.

Ann Surg Oncol. 2016 Jan;23(1):250-6. doi: 10.1245/s10434-015-4766-y. Epub 2015 Jul 28.

14.

Effects of tailored risk communications for skin cancer prevention and detection: the PennSCAPE randomized trial.

Glanz K, Volpicelli K, Jepson C, Ming ME, Schuchter LM, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):415-21. doi: 10.1158/1055-9965.EPI-14-0926. Epub 2014 Nov 28.

15.

Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement.

Kim CC, Swetter SM, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Nelson KC, Veledar E, Venna SS, Chen SC.

JAMA Dermatol. 2015 Feb;151(2):212-8. doi: 10.1001/jamadermatol.2014.2694. Review.

PMID:
25409291
16.

Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.

Bartlett EK, Gimotty PA, Sinnamon AJ, Wachtel H, Roses RE, Schuchter L, Xu X, Elder DE, Ming M, Elenitsas R, Guerry D, Kelz RR, Czerniecki BJ, Fraker DL, Karakousis GC.

Ann Surg Oncol. 2014 Feb;21(2):643-9. doi: 10.1245/s10434-013-3313-y. Epub 2013 Oct 12.

17.

Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.

Glanz K, Volpicelli K, Kanetsky PA, Ming ME, Schuchter LM, Jepson C, Domchek SM, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):607-14. doi: 10.1158/1055-9965.EPI-12-1174. Epub 2013 Feb 7.

18.

MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations.

Nybakken GE, Sargen M, Abraham R, Zhang PJ, Ming M, Xu X.

Am J Dermatopathol. 2013 Feb;35(1):25-9. doi: 10.1097/DAD.0b013e31825666c3.

19.

An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis.

Abraham RM, Ming ME, Elder DE, Xu X.

J Cutan Pathol. 2012 Jan;39(1):21-4. doi: 10.1111/j.1600-0560.2011.01849.x.

20.

Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma.

Xu X, Chen L, Guerry D, Dawson PR, Hwang WT, VanBelle P, Elder DE, Zhang PJ, Ming ME, Schuchter L, Gimotty PA.

Clin Cancer Res. 2012 Jan 1;18(1):229-37. doi: 10.1158/1078-0432.CCR-11-0490. Epub 2011 Nov 17.

Supplemental Content

Loading ...
Support Center